CONFERENCE PROCEEDING
TOB-G: Tobacco Cessation Guidelines for High risk Populations
 
More details
Hide details
1
European Network for Smoking and Tobacco Prevention (ENSP), Belgium
 
2
The American College of Chest Physicians (ACCP), USA
 
 
Submission date: 2016-03-30
 
 
Acceptance date: 2016-03-31
 
 
Publication date: 2016-03-31
 
 
Corresponding author
Panagiotis Behrakis   

European Network for Smoking and Tobacco Prevention (ENSP), Belgium, Ipitou 17B, Plaka, 10557 Athens, Greece
 
 
Tob. Prev. Cessation 2016;2(April Supplement):39
 
KEYWORDS
TOPICS
ABSTRACT
The TOB-G project is funded under the EU 3rd Health Programme which is the main instrument that the Commission uses to implement the EU Health Strategy. The project started in June 2014 and will be completed in September 2017. The project consortium consists of 5 partners from 4 European countries (Belgium, Greece, Ireland and Romania). The TOB-G project aims to develop and implement an innovative and cost effective approach to prevent chronic diseases related to tobacco dependence by focusing on creating specialized tobacco cessation guidelines for populations of high risk including adolescents, pregnant women, adults with COPD, Cardiovascular disease and diabetes. The specialized guidelines for high risks groups will be developed according to ENSP’s evidence based and good practices in tobacco cessation. The smoking cessation guidelines contain strategies and recommendations designed to assist clinicians/ doctors in delivering and supporting effective treatments for tobacco use and dependence and will also be available within the context of an e-learning platform for European clinicians. Overall, the TOB-G project will enhance the overall European capacity in the treatment of tobacco dependence, through offering smoking cessation tools, appropriately assessed and fitted to the specific needs of high risk groups.
 
CITATIONS (7):
1.
Impact of the Tobacco Treatment Guidelines for High Risk Groups (TOB.g): A pilot study among physicians specializing in CVD, Diabetes and COPD
Antigona Trofor, Sophia Papadakis, Constantine Vardavas, Lucia Maria Lotrean, Christina-Maria Gavrilescu, Vasso Evangelopoulou, Theodosia Peleki, Letitia Trofor (PhD student), Panagiotis Κ. Behrakis
Tobacco Prevention & Cessation
 
2.
Tobacco Treatment Guideline for High Risk Groups: A pilot study in patients with Chronic Obstructive Pulmonary Disease
Antigona Trofor, Sophia Papadakis, Lucia Lotrean, Ioana Buculei- Porosnicu, Vergina Vyzikidou, Vaso Evangelopoulou, Constantine Vardavas, Panagiotis Behrakis
Tobacco Induced Diseases
 
3.
A pilot study of the Tobacco Treatment Guidelines for High-Risk Groups (TOB-G) for pregnant and postpartum women
Sophia Papadakis, Vergina Vyzikidou, Victoria Vivilaki, Constantine Vardavas, Andriani Loukopoulou, Theodosia Peleki, Vaso Evangelopoulou, Panagiotis Behrakis
European Journal of Midwifery
 
4.
The TOBg Tobacco Treatment Guidelines for Adolescents: A real-world pilot study
Anastasios Fotiou, Myrto Stavrou, Sophia Papadakis, Panagiotis Behrakis, Constantine Vardavas, Maria Kyriakidou, Sotiria Makaroni, Theodosia Peleki, Vergina Vizikidou, Anna Kokkevi
Tobacco Prevention & Cessation
 
5.
Smoking cessation in pregnancy: An update for maternity care practitioners
Athina Diamanti, Sophia Papadakis, Sotiria Schoretsaniti, Nikoletta Rovina, Victoria Vivilaki, Christina Gratziou, Paraskevi Katsaounou
Tobacco Induced Diseases
 
6.
Long‐term impact of tobacco exposure during pregnancy on children's psychomotor development
Aurela Saliaj, Majlinda Zahaj, Prifti Vasilika, Enkeleint‐Aggelos Mechili
Pediatrics International
 
7.
Airway diseases
Baris Argun, Fusun Yildiz
 
eISSN:2459-3087
Journals System - logo
Scroll to top